Joaquin Guinea, INNOVATEC
European regions network for Health
Research & Innovation (RegHealth-RI)
project
Brussels, 17th November, 2014
RegHealth-RI Coordinator
RegHealth-RI PROJECT KICK-OFF MEETING17-18 November 2014, Brussels
HCO-14-2014--Bridging the divide in European health research and innovation
http://ec.europa.eu/research/participants/portal/desktop/en/opportunities/h2020/topics/2217-hco-14-2014.html
0
2
4
6
8
10F
inla
nd
Sw
ed
en
De
nm
ark
Ge
rma
ny
Au
str
ia
Slo
ve
nia
Es
ton
ia
Fra
nc
e
Be
lgiu
m
Ne
the
rla
nd
s
Un
ite
d K
ing
do
m
Ire
lan
d
Czec
h R
ep
ub
lic
Po
rtu
ga
l
Lu
xem
bo
urg
Sp
ain
Ita
ly
Hu
ng
ary
Lit
hu
an
ia
Cro
ati
a
Po
lan
d
Ma
lta
Latv
ia
Slo
va
kia
Gre
ec
e
Bu
lga
ria
Cyp
rus
Ro
ma
nia
Sw
itze
rla
nd
Icela
nd
No
rwa
y
Tu
rke
y
Se
rbia
Capital region
National average
Other NUTS regions
*Source: Eurostat regional yearbook 2014 (http://epp.eurostat.ec.europa.eu/portal/page/portal/publications/regional_yearbook)
Regional disparities in R&D intensity, by NUTS 2 regions, 2011*
(total R&D expenditure as a % of GDP)
*Source: Eurostat regional yearbook 2014 (http://epp.eurostat.ec.europa.eu/portal/page/portal/publications/regional_yearbook)
Regional disparities in R&D intensity, by NUTS 2 regions, 2011*
(total R&D expenditure as a % of GDP)
Regional disparities in competitiveness for the innovation sub-index, by
NUTS 2 regions, 2013 (1)(EU-28 = 0)
*Source: Eurostat regional yearbook 2014 (http://epp.eurostat.ec.europa.eu/portal/page/portal/publications/regional_yearbook)
Regional competitiveness for selected dimensions of the innovation sub-index,
by NUTS 2 regions, 2013
*Source: Eurostat regional yearbook 2014 (http://epp.eurostat.ec.europa.eu/portal/page/portal/publications/regional_yearbook)
European Commission. (2013). Research and Innovation Performance in EU Member States and Associated Countries 2013 (http://ec.europa.eu/research/innovation-union/pdf/state-of-the-union/2012/innovation_union_progress_at_country_level_2013.pdf)
HEALTH - Scientific publications (2000-09) and Technological production (EPO
patents, 2000-10) in EU Regions
• TO REDUCE THE GAPS IN HEALTH R&I ACROSS THE EU REGIONS
• TO INCREASE THE PARTICIPATION IN HORIZON2020
• TO FACILITATE SYNERGIES BETWEEN HORIZON2020 AND STRUCTURAL FUNDS
REGHEALTH-RI MAIN OBJECTIVES
TO PROPOSE NEW INITIATIVES AND CONCRETE APPROACHESTO EU, NATIONAL AND REGIONAL DECISION-MAKERS:
• Sociedad para el Fomento de la Innovacion Tecnológica (Innovatec) - Coordinator
• European Regional and Local Health Authorities (EUREGHA)
• University of Trieste
• Prof. Jerzy Duszynski, former Deputy Minister of Science of Poland. At present he is the head of the laboratory of Bioenergetics, Nencki Institute of Experimental Biology, Warsaw – Poland
• Prof. Toivo Maimets, former Minister of Education and Research of Estonia. At present he is Prof. at the Univ. of Tartu and member of the Estonian Research Council Gov. Board – Estonia
• Mrs. Illiana Paunova, Chairperson of the Association of the Research-based Pharmaceutical Manufacturers in Bulgaria and General Manager of GlaxoSmithKline Bulgaria – Bulgaria
• Prof. Ana Stavljenic-Rukavina, former Minister of Health of Croatia. At present she is Dean at DIU Libertas International University, Zagreb – Croatia
• Mrs. María José Muñoz Martínez, Directorate General of Community Funds, Ministry of Finance and Public Administration – Spain
• Prof. Jonathan Watson, Co-Founder INTEGRATE; Special Professor of Health & Public Policy, Univ. of Nottingham; External Expert to DG REGIO; Executive Director Health ClusterNet – UK
ADVISORY BOARD MEMBERS
PROJECT PARTNERS
RegHealth-RI
• August Kirchenstein Institute of Microbiology and Virology. Riga Stradins University – Latvia
• Business & Innovation Centre (BIC) of Epirus – Greece
• Comissão de Coordenação e Desenvolvimento Regional (CCDR) do Algarve – Portugal
• Democritus University of Thrace, Department of Molecular Biology and Genetics
• Estonian HealthTech Cluster – Estonia
• Estonian Research Council (Horizon 2020 National Contact Point on Health) – Estonia
• Fundación Pública Andaluza Progreso y Salud – Spain
• Inkubator d.o.o. Sežana – Slovenia
• Innovative Pharmaceutical Industry Association (IFPA) of Lithuania – Lithuania
• Intermediate Managing Authority Region of Western Greece – Greece
• Marche Region. Department of Research and Innovation – Italy
• Marshall Office of Lubelskie Voivodeship, Dep. of Economy and Innovation – Poland
• Marshal's Office Świętokrzyskie. Office of Innovation – Poland
• MidTECH. National Health Service (NHS) Innovation Hub For The West Midlands – UK
• Ministry of Education, Science and Sport – Slovenia
• Ministry of Education and Science, Study and Research Administration – Latvia
• National Documentation Centre – Greece
• North-East Regional Development Agency (ADR Nord-Est) – Romania
• Nutrition, Health and Longevity (NHL) Cluster (Lille) – France
• Ovidius University / Clinical Hospital of Infectious Diseases, Constanța – Romania
• Research Park, Autonomous University of Barcelona – Spain
• Slovak Association of Research Based Pharmaceutical Companies (SAFS) – Slovakia
• South Transdanubian Regional Innovation Agency – Hungary
• St. Anne's University Hospital in Brno-Int. Clinical Research Center –- Czech Republic
RegHealth-RI ASSOCIATE PARTNERS
WP4: Dissemination activities
The European regions network for Health Research and Innovation (RegHealth-RI) WORK PLAN SUMMARY: Planned Work Packages (WPs) and Events
1st Year
WP1: State of the Art of health R&I in EU regions and identification and analysis of determinants influencing its performance and progression
WP5: Management
2nd Year
2nd Workshop:“New approaches for bridging the divide in health R&I in the EU
regions”
WP2: Creation of a NETWORKING PLATFORM and organization of three Workshops to discuss the divide in European Health R&I and possible solutions
3rd Workshop: “HORIZON 2020: Synergies with
Structural Funds and new ways for
widening the participation”
WP3: 1st
European Conference: “Bridging the divide in European health R&I”
1st European Conference: “BRIDGING THE
DIVIDE IN EUROPEAN
HEALTH R&I”
1st Workshop: “Analysis of Health
R&I in less performing EU
regions: Present situation, possible
causes and influencing factors”
Starting date: 01-Nov-2014
WP2
• WORKSHOPS REPORTS • PRESENTATIONS• PRESS RELEASES• POLICY BRIEFS
WS1: ‘”Analysis of Health R&I in less performing EU regions: Present situation and new perspectives’”
Planned Deliverables
WS2: “New approaches for bridging the divide in health R&I in the EU regions”
WS3: “Horizon 2020: Synergies with Structural Funds and new ways for widening the participation”
WP1
State of the Art of the health research and innovation (R&I) in less performing regions
Launching the REGHEALTH-RI Networking Platform
WP3
1st European Conference - ‘Bridging the divide in European health R&I’
• CONFERENCE REPORT • PRESENTATIONS• PRESS RELEASES• POLICY BRIEFS
•WEBSITE •NETWORKING TOOLS
• FINAL PUBLISHABLE SUMMARY REPORT
Universities and R&D centers
Health & Biotech clusters
Companies (pharma, biotech,
etc.)
Sci. & Tech Parks, Incubators, e
tc.
National and Regional authorities
EXPECTED IMPACT ON:• WIDENING PARTICIPATION
• BRIDGING THE INNOVATION DIVIDE
• SYNERGIES BETWEEN H2020 AND
STRUCTURAL FUNDS
POLICY AND DECISSION MAKING
EU :DG REGIO
DG Research & Inn.
DISSEMINATION (WP4)
• STATE OF THE ART REPORT • ACADEMIC DOCUMENTS
RegHealth-RI EXPECTED IMPACT
• Determining the State of the Art of the health Research and Innovation (R&I) activities in EU regions looking for key factors, specific differences and common patterns which could explain the differences between them
• Designing and developing indicators (qualitative and quantitative) to measure the degree of development of the health R&I across the European regions
• To elaborate a detailed report depicting the current situation as well as common patterns, differences or factors influencing on the health R&I across EU regions
WP1: STATE OF THE ART OF HEALTH RESEARCH AND INNOVATION (R&I) IN EU REGIONS AND IDENTIFICATION AND ANALYSIS OF DETERMINANTS INFLUENCING ITS PERFORMANCE AND PROGRESSION
MAIN OBJECTIVES Health
Definition/Classification
DATA SOURCES EVIDENCE-BASED ANALYSIS
PROCESSING
R&D EXPENDITUREEUROSTAT
HEALTH DATA ON INFRAESTRUCTURES, TRAINING, CLINICAL TRIALS, ETC.GOVERNMENT WEBS (MINISTRY OF HEALTH, SCI. & RESEARCH…)INSTITUTIONAL REPOSITORIESPUBLIC REPORTSOTHERS
Data RetrievalHealth Delineation:
Search Strategies
Regional Aggregations
National Disaggregations
DATA FORMATTING•Tabulation,•Correction•Etc…
REPORT: State of the Art of health Research and Innovation (R&I) in EU regions and identification and analysis of determinants influencing its performance and progression
OUTPUT
Multivariate Analysis: Cluster, PCA…
Descriptive Stats: Means, Variance…
Linear Regression Analysis
Development of Indicators
HEALTH / BIOTECH PUBLICATIONS AND PATENTS - (DG RES. & INNOV.)EC (2013). Research and innovation performance in EU Member States and associated countries – Innovation Union progress at country level
RIS3 Eye@RIS3
• The launching of the European regions network for Health Research and Innovation Platform (RegHealth-RI Platform, tentative name) is an important goal of the project
• Will be composed of actors from different EU organizations with interest and targets in promoting health R&I at regional, national or European level.
• The main objective of this networking platform will be to promote and facilitate the communication between network members to enrich the dialogue, the feedback and exchange of opinions and experiences among the members.
• Several networking tools like the network webpage, discussion forums, collaborative work tools (wiki or similar), social network tools and intranet, will be implemented to facilitate the communication. The intranet of the network website could include repositories including the following types of documents:
LAUNCH OF A NETWORKING PLATFORM
• Examples of successful approaches to obtain synergies between H2020 and SF
• Good practices for health/ biotech cluster development.
• Successful regional programmes promoting collaboration between academic centres andcompanies in the health sector.
• Good practices for academic spin-off promoting programmes.
• Key points to take into account when promoting technology transfer between academicresearch centres and private companies in the health sector.
• Methodologies and tools for identifying and assessing the impact of the R&I regionalprogrammes addressing the health sector.
Consortium
Potential Members
H2020 NCPs
Health & Biotech Clusters
Sci. & Tech Parks, Incubator
s, etc.
National and Regional
authorities
Companies (pharma, biotec
h, etc.)
Practitioners
Initial Members (Associated Partners, etc.)
Universities and R&D centers
Health & Biotech clusters
H2020 NCPs
Companies (pharma, biotec
h, etc.)
Sci. & Tech Parks, Incubator
s, etc.
Practitioners
Civil Society Org.
Core Partners
Advisory Board
DisseminationNetworking
•Forums•Wiki•Intranet
•Flyer•Brochure•P. Releases•Newsletters
Registration Form
WEBSITE
RegHealth-RI Network
Universities and R&D centers
Civil Society Org.
National and Regional
authorities
Timing (month from staring the
project)
Title(preliminary)
Organizer / Place
(prelim.)
Objectives of the Workshop /Conference
(preliminary)
Participants
1st Workshop7th month
Analysis of Health R&I in less performing EU regions: Present situation, possible causes and influencing factors
Innovatec /Madrid
Analyses of the regional disparities: determin.s, common patterns, FP7 particip., RIS3 strat. etc.,
Causes and influencing factors: low invest. in R&D, scant infrastruct., lack of training prog., etc.
- Partners- Assoc. Partners- Advisory Board- 10-15 experts /authorities[Tot. aprox. 40-45]
2nd Workshop13th month
New approaches for bridging the divide in health R&I in the EU regions
Nencki Institute /Warsaw
Discuss and agree on different approaches for bridging the divide in health R&I
- Partners- Assoc. Partners- Advisory Board- 10-15 experts /authorities- [Tot. aprox. 40-45]
3rd Workshop19th month
Horizon 2020: Synergies with Structural Funds and new ways for widening the participation
To be decided
Discuss and agree on different approaches for increasing H2020: synergies with SF and for widening its participation
- Partners- Assoc. Partners- Advisory Board- 10-15 experts /authorities[Tot. aprox. 40-45]
1st European Conference23rd month
Bridging the divide in European health R&I
EUREGHA / Brussels
Analysis of the sit. of health R&I in EU regions
Presentation of new approaches agreed in the Workshops for bridging the divide, incr. synergies & widening the particip.
- Partners- Assoc. Partners- Advisory Board- 50-60 invited persons
included DG Research, DG Regio, DG SANCO and COST officers
[Tot. aprox. 80-100]
THEMATIC WORKSHOPS AND ORGANIZATION OF THE 1ST CONFERENCE ON "BRIDGING THE DIVIDE IN EUROPEAN HEALTH R&I" (preliminary name)
• Introduction of health R&I strategies and targets in organizations representing the regions
• State of the Art of the health R&I) in regions (advanced draft document produced during WP1):
Analysis of the regional disparities in terms of health research and innovation.
Detection of common patterns and study of determinants on health R&I within the less performing EU regions.
Analysis of the participation of low performing European regions in health areas of FP7 program and sub-programs such as Regional Potential, Marie-Curie, etc.
• Causes and influencing factors of the regional disparities in health R&I (preliminary ideas):
Low investment in R&D,
Scant R&I infrastructures,
Lack of doctoral/master programs, etc
• Discussion and analysis of present RIS3 strategies
1st Workshop - Analysis of Health R&I in less performing EU regions: Present situation, possible causes and influencing factors
Topics for discussion (preliminary)
• Identification of actions to reduce the gaps in the R&I on health across the EU regions (preliminary ideas):
Promoting science-industry co-operation and technology transfer and training
Developing regional research infrastructure and centres of competence
Establish new funding programs to develop and disseminate technology innovations within the non-profit sector
Create forums and intermediaries to facilitate the adoption and dissemination of technology innovations
Promote health innovation clusters for regional growth
Support services to innovating firms: i.e. science parks or incubators
Promoting spin-offs from research centres
2nd Workshop - New approaches for bridging the divide in health R&I in the EU regions
Topics for discussion (preliminary)
• Analysis of the results of the Pillar 15 of Horizon 2020: "Spreading Excellence and Widening Participation: Teaming, Twinning, ERA Chairs, the Policy Support Facility and the Special action from COST on Widening actions and its possible synergies with Structural Funds
• Identification of possible actions/initiatives/programmes to increase the participation in H2020 and to facilitate synergies between H2020 and Structural Funds (preliminary ideas):
Design H2020 work programmes taking RIS3 fields and SF implementation timelines into account and include FP7/Horizon2020 participants from less dev. regions, to design RIS3.
Promote actions funded by SFs to support the preparation of proposals for H2020 (search for projects/partners, writing the proposal, budget elaboration, etc.) of both Academic research centres and companies
Promote new doctoral programmes funded by ESIF for increasing its possibilities of additional funding in the Horizon 2020 under the Marie Skłodowska-Curie Actions
Open Horizon 2020 strategic platforms (Joint Programming Initiatives, European Innovation Partnerships, etc.) for regional level policy actors.
3rd Workshop - Horizon 2020: Synergies with Structural Funds and new ways for widening the participation
Topics for discussion (preliminary)
1st European ConferenceBridging the divide in European health R&I
A selection of the most important topics discussed during the previous workshops will be performed
Thank you very much
Joaquin Guinea, INNOVATEC
RegHealth-RI Coordinator
Top Related